444 related articles for article (PubMed ID: 18787185)
1. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468
[TBL] [Abstract][Full Text] [Related]
5. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
6. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ASC-2 as an antiatherogenic transcriptional coactivator of liver X receptors in macrophages.
Kim GH; Park K; Yeom SY; Lee KJ; Kim G; Ko J; Rhee DK; Kim YH; Lee HK; Kim HW; Oh GT; Lee KU; Lee JW; Kim SW
Mol Endocrinol; 2009 Jul; 23(7):966-74. PubMed ID: 19342446
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
9. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
[TBL] [Abstract][Full Text] [Related]
10. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
[TBL] [Abstract][Full Text] [Related]
11. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha.
Lu KY; Ching LC; Su KH; Yu YB; Kou YR; Hsiao SH; Huang YC; Chen CY; Cheng LC; Pan CC; Lee TS
Circulation; 2010 Apr; 121(16):1828-37. PubMed ID: 20385932
[TBL] [Abstract][Full Text] [Related]
13. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
14. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL.
Wang N; Ranalletta M; Matsuura F; Peng F; Tall AR
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1310-6. PubMed ID: 16556852
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
Wang N; Lan D; Chen W; Matsuura F; Tall AR
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
[TBL] [Abstract][Full Text] [Related]
17. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages.
Ning Y; Bai Q; Lu H; Li X; Pandak WM; Zhao F; Chen S; Ren S; Yin L
Atherosclerosis; 2009 May; 204(1):114-20. PubMed ID: 18945429
[TBL] [Abstract][Full Text] [Related]
20. Autoregulation of the human liver X receptor alpha promoter.
Laffitte BA; Joseph SB; Walczak R; Pei L; Wilpitz DC; Collins JL; Tontonoz P
Mol Cell Biol; 2001 Nov; 21(22):7558-68. PubMed ID: 11604492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
